Release Date: 31/10/18 18:17 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 151.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%